The R&D 100 winning technology, Time of Flight Cascade Gamma Ray Imaging, developed by Nuclear Science Division researchers, generates images of very low concentrations of radionuclides emitting cascade gamma rays, extending the capabilities of nuclear medicine scanners to enable advanced therapies such as Targeted Alpha Therapy for cancer.
